{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:56:45Z","timestamp":1768291005330,"version":"3.49.0"},"reference-count":38,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,5,31]]},"DOI":"10.1536\/ihj.24-667","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T22:07:59Z","timestamp":1747260479000},"page":"375-384","source":"Crossref","is-referenced-by-count":1,"title":["Utility and Limitations of Genetic Testing in the Routine Care of Cardiovascular Disease Patients in a General Hospital"],"prefix":"10.1536","volume":"66","author":[{"given":"Daiki","family":"Tomidokoro","sequence":"first","affiliation":[{"name":"Medical Genomics Center, Research Institute, National Center for Global Health and Medicine"},{"name":"Department of Cardiology, Center Hospital, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Mori","sequence":"additional","affiliation":[{"name":"Medical Genomics Center, Research Institute, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center Hospital, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Isono","sequence":"additional","affiliation":[{"name":"Medical Genomics Center, Research Institute, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kozue","family":"Takano","sequence":"additional","affiliation":[{"name":"Medical Genomics Center, Research Institute, National Center for Global Health and Medicine"},{"name":"Department of Genomic Medicine, Center Hospital, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Genomic Medicine, Center Hospital, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Medical Genomics Center, Research Institute, National Center for Global Health and Medicine"},{"name":"Department of Genomic Medicine, Center Hospital, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Medical Genomics Center, Research Institute, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center Hospital, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Hiroi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Center Hospital, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Medical Genomics Center, Research Institute, National Center for Global Health and Medicine"},{"name":"Department of Genomic Medicine, Center Hospital, National Center for Global Health and Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cirino AL, Harris S, Lakdawala NK, <i>et al<\/i>. Role of Genetic Testing in Inherited Cardiovascular Disease: A Review. JAMA Cardiol 2017; 2: 1153-60.","DOI":"10.1001\/jamacardio.2017.2352"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Gersh BJ, Maron BJ, Bonow RO, <i>et al<\/i>. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: e783-831.","DOI":"10.1161\/CIR.0b013e318223e2bd"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Ackerman MJ, Priori SG, Willems S, <i>et al<\/i>. HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 2011; 13: 1077-109.","DOI":"10.1093\/europace\/eur245"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Authors\/Task Force members; Elliott PM, Anastasakis A, Borger MA, <i>et al<\/i>. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-79.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Priori SG, Wilde AA, Horie M, <i>et al<\/i>. HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 2013; 10: 1932-63.","DOI":"10.1016\/j.hrthm.2013.05.014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dellefave-Castillo LM, Cirino AL, Callis TE, <i>et al<\/i>. Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing. JAMA Cardiol 2022; 7: 966-74.","DOI":"10.1001\/jamacardio.2022.2455"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Janin A, Januel L, Cazeneuve C, Delini\u00e8re A, Chevalier P, Millat G. Molecular Diagnosis of Inherited Cardiac Diseases in the Era of Next-Generation Sequencing: A Single Center&apos;s Experience Over 5 Years. Mol Diagn Ther 2021; 25: 373-85.","DOI":"10.1007\/s40291-021-00530-w"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Park J, Packard EA, Levin MG, <i>et al<\/i>. A genome-first approach to rare variants in hypertrophic cardiomyopathy genes MYBPC3 and MYH7 in a medical biobank. Hum Mol Genet 2022; 31: 827-37.","DOI":"10.1093\/hmg\/ddab249"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Marian AJ, Braunwald E. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res 2017; 121: 749-70.","DOI":"10.1161\/CIRCRESAHA.117.311059"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tadros R, Francis C, Xu X, <i>et al<\/i>. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect. Nat Genet 2021; 53: 128-34.","DOI":"10.1038\/s41588-020-00762-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Harper AR, Goel A, Grace C, <i>et al<\/i>. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat Genet 2021; 53: 135-42.","DOI":"10.1038\/s41588-020-00764-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yoneda ZT, Anderson KC, Quintana JA, <i>et al<\/i>. Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes. JAMA Cardiol 2021; 6: 1371-9.","DOI":"10.1001\/jamacardio.2021.3370"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Choi SH, Jurgens SJ, Weng LC, <i>et al<\/i>. Monogenic and Polygenic Contributions to Atrial Fibrillation Risk: Results From a National Biobank. Circ Res 2020; 126: 200-9.","DOI":"10.1161\/CIRCRESAHA.119.315686"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miyazawa K, Ito K, Ito M, <i>et al<\/i>. Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. Nat Genet 2023; 55: 187-97.","DOI":"10.1038\/s41588-022-01284-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kernohan KD, Boycott KM. The expanding diagnostic toolbox for rare genetic diseases. Nat Rev Genet 2024; 25: 401-15.","DOI":"10.1038\/s41576-023-00683-w"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cerrone M, Remme CA, Tadros R, Bezzina CR, Delmar M. Beyond the One Gene-One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders. Circulation 2019; 140: 595-610.","DOI":"10.1161\/CIRCULATIONAHA.118.035954"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Harada-Shiba M, Arai H, Ohmura H, <i>et al<\/i>. Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022. J Atheroscler Thromb 2023; 30: 558-86.","DOI":"10.5551\/jat.CR005"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Chelliah RK, Senior R. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation. Future Cardiol 2009; 5: 495-502.","DOI":"10.2217\/fca.09.34"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Miyake W, Minemoto M, Hayama H, <i>et al<\/i>. Case Report of Left Ventricular Noncompaction Cardiomyopathy Characterized by Undulating Phenotypes in Adult Patients. Int Heart J 2021; 62: 1420-9.","DOI":"10.1536\/ihj.21-283"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. DiStefano MT, Goehringer S, Babb L, <i>et al<\/i>. The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med 2022; 24: 1732-42.","DOI":"10.1016\/j.gim.2022.04.017"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ioannidis NM, Rothstein JH, Pejaver V, <i>et al<\/i>. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet 2016; 99: 877-85.","DOI":"10.1016\/j.ajhg.2016.08.016"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Richards S, Aziz N, Bale S, <i>et al<\/i>. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-24.","DOI":"10.1038\/gim.2015.30"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pejaver V, Byrne AB, Feng BJ, <i>et al<\/i>. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet 2022; 109: 2163-77.","DOI":"10.1016\/j.ajhg.2022.10.013"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Imai Y, Kusano K, Aiba T, <i>et al<\/i>. JCS\/JCC\/JSPCCS 2024 Guideline on Genetic Testing and Counseling in Cardiovascular Disease. Circ J 2024; 88: 2022-99.","DOI":"10.1253\/circj.CJ-23-0926"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2014; 89: 727-37.","DOI":"10.1016\/j.mayocp.2014.01.025"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Moriki T, Kubo T, Sugiura K, <i>et al<\/i>. A Validation Study of the Mayo Clinic Phenotype-Based Genetic Test Prediction Score for Japanese Patients With Hypertrophic Cardiomyopathy. Circ J 2021; 85: 669-74.","DOI":"10.1253\/circj.CJ-20-0826"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Guo MH, Plummer L, Chan YM, Hirschhorn JN, Lippincott MF. Burden Testing of Rare Variants Identified through Exome Sequencing via Publicly Available Control Data. Am J Hum Genet 2018; 103: 522-34.","DOI":"10.1016\/j.ajhg.2018.08.016"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Aung N, Lopes LR, van Duijvenboden S, <i>et al<\/i>. Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy. Circ Genom Precis Med 2023; 16: e003716.","DOI":"10.1161\/CIRCGEN.122.003716"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nakashima Y, Kubo T, Sugiura K, <i>et al<\/i>. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy. Circ J 2020; 84: 1846-53.","DOI":"10.1253\/circj.CJ-20-0027"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Forrest IS, Duffy \u00c1, Park JK, <i>et al<\/i>. Genome-first evaluation with exome sequence and clinical data uncovers underdiagnosed genetic disorders in a large healthcare system. Cell Rep Med 2024; 5: 101518.","DOI":"10.1016\/j.xcrm.2024.101518"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Khera AV, Won HH, Peloso GM, <i>et al<\/i>. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. J Am Coll Cardiol 2016; 67: 2578-89.","DOI":"10.1016\/j.jacc.2016.03.520"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Taylor A, Wang D, Patel K, <i>et al<\/i>. Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet 2010; 77: 572-80.","DOI":"10.1111\/j.1399-0004.2009.01356.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Walsh R, Thomson KL, Ware JS, <i>et al<\/i>. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med 2017; 19: 192-203.","DOI":"10.1038\/gim.2016.90"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Mazzarotto F, Olivotto I, Boschi B, <i>et al<\/i>. Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? J Am Heart Assoc 2020; 9: e015473.","DOI":"10.1161\/JAHA.119.015473"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Walsh S, Cirino A, Hansen B, <i>et al<\/i>. Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis. Open Heart 2022; 9: e001815.","DOI":"10.1136\/openhrt-2021-001815"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Walsh R, Mazzarotto F, Whiffin N, <i>et al<\/i>. Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy. Genome Med 2019; 11: 5.","DOI":"10.1186\/s13073-019-0616-z"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Biddinger KJ, Jurgens SJ, Maamari D, <i>et al<\/i>. Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank. JAMA Cardiol 2022; 7: 715-22.","DOI":"10.1001\/jamacardio.2022.1061"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Gidding SS, Kirchner HL, Brangan A, <i>et al<\/i>. Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening. J Am Heart Assoc 2023; 12: e030073.","DOI":"10.1161\/JAHA.123.030073"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/3\/66_24-667\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:04:36Z","timestamp":1748664276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/3\/66_24-667\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-667","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"article-number":"24-667"}}